Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Mitomycin (Primary)
- Indications Bladder cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms OPTIMA
- Sponsors UroGen Pharma
- 15 Jun 2017 Status changed from active, no longer recruiting to completed.
- 18 Aug 2016 Planned End Date changed from 1 Jun 2017 to 1 Jul 2017.
- 10 May 2016 Preliminary results (n=55) presented at the 111th Annual Meeting of the American Urological Association